Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Pharma
JPM26: Novo CEO outlines R&D, marketing tactics for 2026
During a presentation, Maziar Doustdar—who was tapped to lead Novo Nordisk last summer—didn’t hesitate to acknowledge the company’s “difficult 2025.”
Fraiser Kansteiner
Jan 14, 2026 10:05am
AbbVie locks in US pricing deal as it pledges $100B investment
Jan 13, 2026 9:15am
Fierce Biotech
Valneva closes site to consolidate R&D footprint, lays off 30
Nov 26, 2025 12:57pm
Moderna outlines 3-year business strategy in bid to break even
Nov 20, 2025 2:54pm
Senate backs China competition amendment in defense bill
Oct 10, 2025 10:56am
AbbVie unveils $70M expansion in MA
Oct 1, 2025 9:05am
